Long-Term Outcomes of Elagolix in Women With Endometriosis

Eric S. Surrey(Colorado Center for Reproductive Medicine), Kristof Chwalisż(AbbVie (United States)), Nicholas Leyland(McMaster University), W. Rachel Duan(AbbVie (United States)), Linda C. Giudice(University of California, San Francisco), John C. Gallagher(University of Cincinnati), Bruce A. Lessey(Atrium Health Wake Forest Baptist), Brittany Schwefel(AbbVie (United States)), Tomasz Rechberger(Medical University of Lublin), Paul M. Peloso(Genoscience Pharma (France)), Hugh S. Taylor(Yale University), James A. Simon(George Washington University), Sanjay K. Agarwal(Creighton University), Sukhbir S. Singh(University of Ottawa), Juki Ng(AbbVie (United States)), Nelson B. Watts(Mercy Health), Ahmed M. Soliman(AbbVie (United States)), James W. Thomas(National Institutes of Health), Bruce R. Carr(University of Florida), David F. Archer(Eastern Virginia Medical School), Neil P. Johnson(The University of Adelaide), Maurício Simões Abrão(Beneficência Portuguesa de São Paulo), W. Paul Dmowski(Creighton University), Michael P. Diamond(Augusta University)
Obstetrics and Gynecology
June 10, 2018
Cited by 132


Related Papers